Tag Archives: Cord blood

Cord blood bank from New England reports raised use of stored Stem Cells

(…) Since 2006, according to NECBB records, the number of banked units used in transplants has doubled. The company attributes this increase in cord blood usage to the ever evolving research surrounding cord blood stem cells.

“We have always reminded parents that stem cell therapies are advancing very quickly and it is difficult to know what the possibilities are. The fact that more parents are using cells they stored suggests that the scope of treatments available is encouraging,” said Dr. David Matzilevich, Chief Scientific Officer of NECBB. “We are confident that the cells found in cord blood are extremely valuable
Read More…

South Korea approves stem cell drug

South Korea’s government drug agency cleared the way Thursday for commercial sales of what it called the world’s first approved medicine using stem cells collected from other people.

Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using stem cells developed from newborns’ umbilical cord blood, the Korea Food and Drug Administration said.

“Cartistem is… the world’s first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis,” the administration said in a statement.

Medipost said 27 billion won ($23.8 million) from private investors and government
Read More…

Boy whose skin can’t attach is healing

http://mediamill.cla.umn.edu/mediamill/download.php?file=13798.flv#/U_of_M_Sets_Course_For_Cure_of_Fatal_Childhood_Skin_Disease___Academic_Health_Center__University_of_Minnesota_download.php.flv

Physicians at the University of Minnesota and University of Minnesota Children’s Hospital, Fairview have set the path to a cure for a young boy’s fatal genetic skin disease, recessive dystrophic epidermolysis bullosa (RDEB), by using a cord blood and bone marrow transplant. Nate Liao, a 25-month-old from Clarksburg, N.J., underwent the experimental therapy in October 2007.

“We have established a new standard of care for these EB patients, beginning with Nate,” said John Wagner, M.D., the lead University of Minnesota Medical School physician who developed the clinical trial. “Nate’s quality of life is forever changed.”

Because they lack collagen type VII,
Read More…

Treatment for stem-cell transplants shows promise

An innovative experimental treatment for boosting the effectiveness of blood stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, according to Harvard Stem Cell Institute (HSCI) scientists at Dana-Farber Cancer Institute (DFCI), Beth Israel Deaconess Medical Center (BIDMC), and Children’s Hospital Boston (CHB).

Analysis of long-term safety testing in nonhuman primates, published online by the journal Cell Stem Cell in a new section called “Clinical Progress,” revealed that a year following transplant umbilical cord blood units treated with a signaling molecule called 16,16-dimethyl PGE2 reconstituted all the normal types
Read More…

India: bank heavily on stem cells

Stem Cell Therapy

Stem cell banking is gaining popularity in Indore and Bhopal as increasing numbers of parents are taking to the concept, which has the potential to secure their child’s healthy life.

The number of people who have registered for stem cell banking has increased multifold in Indore and Bhopal, placing them among the top 10 cities in the country, according to industry estimates.

Every month about 500 parents from Indore and Bhopal are investing in the potential life-saving power of stem cells by preserving the umbilical cord at child birth, whose stem cells help fight against any future life
Read More…